跳至主要内容
临床试验/EUCTR2014-002827-87-NL
EUCTR2014-002827-87-NL进行中(未招募)不适用

Multicenter randomized controlled trial comparing Ferric(III)carboxymaltose infusion with oral iron suppletion in the treatment of preoperative anemia in colorectal cancer patients - FIT trial

Academic Medical Center0 个研究点开始时间: 2014年10月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Colorectal carcinoma
  • -Laparoscopic or open segment resection or a low anterior resection
  • -Iron deficiency anemia: Hb <7,5mmol/l (12 g/dl) for women and Hb <8 mmol/l (13 g/dl) for men en TSAT<20%
  • -Age 18 years or older
  • -Written informed consent for study participation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 70
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 128

排除标准

  • -Palliative surgery / metastasized disease
  • -Received blood transfusion within one month before screening
  • -Serum ferritin = 800 µg/L
  • -Pregnancy
  • -Preoperative chemoradiation (Short 5x5gy = no exclusion)
  • -Contraindication for the use of Ferric(III)carboxymaltose or ferrofumarate
  • -ASA classification > 3
  • -Use of erythropoietin stimulating agents within three months before screening
  • -Chronic kidney disease (GFR < 30ml/min/m)
  • -Myelodysplastic syndrome
  • -Severe anemia with indication for blood transfusion
  • -Hereditary Heamochromatosis
  • -Thalassemia
  • -Hemolytic anemia/ chronic hemolysis

研究者

发起方
Academic Medical Center

相似试验

Multicenter randomized controlled trial comparing... | 临床试验